Resmed Inc. buy KeyCorp
Start price
30.01.26
/
50%
€222.50
Target price
30.01.27
-
Performance (%)
-17.75%
Price
31.07.26
€183.00
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.75%. This prediction currently runs until 30.01.27. The prediction end date can be changed by KeyCorp at any time. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 6.519% | 6.519% |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "overweight" rating reaffirmed by analysts at KeyCorp.
Ratings data for RMD provided by MarketBeat